Document is current
Any future updates will be listed below
-
Authors
Padnick-Silver, Lissa
Concoff, Andrew
Gao, Hong-Ye
Fu, Qianhong
LaMoreaux, Brian https://orcid.org/0000-0001-7521-241X
Edwards, N. Lawrence
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 12 March 2025
Accepted: 23 April 2025
First Online: 20 May 2025
Declarations
:
: Lissa Padnick-Silver was an employee of and stockholder in Amgen, Inc. (formerly Horizon Therapeutics) at the time the study was performed and is currently an employee of and stockholder in AbbVie Inc. Qianhong Fu was an employee of and stockholder in Amgen, Inc. (formerly Horizon Therapeutics) at the time the study was performed and is currently an employee of and stockholder in Beigene. Brian LaMoreaux is an employee of and stockholder in Amgen, Inc. (formerly Horizon Therapeutics). Andrew Concoff is an employee of United Rheumatology and was an employee of Exagen, Inc. Hong-Ye Gao is a paid contractor for Amgen, Inc. (formerly Horizon Therapeutics). N. Lawrence Edwards is a consultant for Amgen, Inc (formerly Horizon Therapeutics) and a member of the United Rheumatology Medical Policy Committee.
: This study examined medical record and insurance claims data in the existing and de-identified UR-NICE, which was available under license for the current study. Because all data were existing and de-identified, this study did not meet the US definition of human subjects research, as defined in the US code of federal regulations (45 CFR 46|HHS.gov) and per the US National Institutes of Health determination tool ().
